The Quest to Conquer Alzheimer’s Disease

Friday, June 7 - 1:00 PM


Alzheimer’s disease has been the most expensive disease in the U.S. since 2013. It cost American society approximately $260 billion in 2017, a sum that will rise to more than $1 trillion by 2050 unless methods to prevent Alzheimer’s disease or significantly slow its progression can be developed soon. To that end, the Bloom lab recently obtained evidence that memantine (Namenda®), an FDA-approved drug for modest and temporary symptom relief in advanced AD patients, may also be able to prevent Alzheimer’s disease. Bloom will discuss how that discovery might lead to a clinical trial to test if daily memantine treatment beginning years before Alzheimer’s disease symptoms develop can prevent or delay symptom onset.

RSVP REQUIRED



Location

Minor Hall, Room 125
Charlottesville, VA 22903
Event Type
Educational

Organization

U.Va. Lifetime Learning

Date / Time

Friday, June 7, 2019
1:00 PM - 2:00 PM

Contact

Name:
Dana
Phone:
(434) 982-4491
Email:
lifetimelearning@virginia.edu
More Info:
https://alumni.virginia.edu/learn/program/research-at-uva-the-quest-to-conquer-alzheimers-disease/